Investment
Features
FeesSafety
Academy
More
Pluang+

Compare InMode Ltd (INMD) vs Progressive Corp (PGR) Price & Performance

InMode LtdTrade
Progressive CorpTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Progressive Corp — how do they compare? InMode Ltd trades at $14.07 (market cap $806.05M), while Progressive Corp trades at $218.9 (market cap $126.95B). The key difference: Progressive Corp is far larger — about 157.5× InMode Ltd's market cap, and Progressive Corp pays a 0.18% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and Progressive Corp for 81 Days on average.

INMDPGR
Market Cap
$806.05M$126.95B
Volume
511,4462,749,438
Sector
HealthFinancials
52-Week High
$16.62$242.16
52-Week Low
$12.76$190.40
Typical Hold Time
29 Days81 Days
Enterprise Value
$309.39M$135.16B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

InMode Ltd

INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.

The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.

Progressive Corp

Progressive Corporation (PGR) trades at $214.12, up 0.98% with a bullish technical outlook. The stock shows strong fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Valuation metrics appear reasonable with P/E of 10.74 and ROE of 34.94%. Recent earnings beat expectations in Q2 2026, and analyst consensus targets $222.23.

PGR presents a compelling investment case with consistent revenue growth and strong profitability. However, investors face risks from intensifying auto insurance competition and potential margin pressure. The stock's current price near resistance levels suggests limited near-term upside despite positive analyst sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INMD

No sentiment data available yet.

PGR
3% Buy97% Sell
Avg holding period · 81 Days

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD →

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR →